GPT and hepatitis A virus infection: While treatment with ConA resulted in liver damage and hepatitis, co-treatment with Phenhydan® greatly diminished plasma alanine aminotransferase (ALT) and aspartate aminotransferase (AST) concentrations, as well as considerably reduced lactate dehydrogenase (LDH) activity (Fig. 6b–d).